Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues
Adinarayana Nandikolla, Singireddi Srinivasarao, Banoth Karan Kumar, et al.
RSC Advances (2020) Vol. 10, Iss. 63, pp. 38328-38343
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

New 2-Chloroimidazo[1,2-a]pyridine induced Schiff bases: Synthesis, characterization, antimicrobial and A-498 and A-549 anticancer activity, molecular modeling, in-silico pharmacokinetics, and DFT studies
Shailesh S. Gurav, Krishnakant T. Waghmode, Shweta N. Dandekar, et al.
Chemical Physics Impact (2024) Vol. 8, pp. 100494-100494
Open Access | Times Cited: 12
Novel isatin–triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies
Alia Mushtaq, Rabbia Asif, Waqar Ahmed Humayun, et al.
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14051-14067
Open Access | Times Cited: 6
Imidazo[1,2-a]pyridine-appended chalcone and Schiff base conjugates: Synthetic, spectrophotometric, biological, and computational aspects
Seema R. Jadhav, Shailesh S. Gurav, Haya Yasin, et al.
Chemical Physics Impact (2024) Vol. 9, pp. 100694-100694
Open Access | Times Cited: 6
Synthetic product-based approach toward potential antileishmanial drug development
Rohit Pal, Ghanshyam Teli, Md Jawaid Akhtar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 263, pp. 115927-115927
Closed Access | Times Cited: 14
Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis
Adinarayana Nandikolla, Singireddi Srinivasarao, Yogesh Mahadu Khetmalis, et al.
Toxicology in Vitro (2021) Vol. 74, pp. 105137-105137
Closed Access | Times Cited: 23
Synthesis and antibiofilm activity of 1,2,3-triazole-pyridine hybrids against methicillin-resistant Staphylococcus aureus (MRSA)
Tamer El Malah, Hanan A. Soliman, Bahaa A. Hemdan, et al.
New Journal of Chemistry (2021) Vol. 45, Iss. 24, pp. 10822-10830
Closed Access | Times Cited: 23
Synthetic and medicinal perspective of antileishmanial agents: An overview
Swati Pawar, Mukesh Kumar Kumawat, Monika Kundu, et al.
Journal of Molecular Structure (2022) Vol. 1271, pp. 133977-133977
Closed Access | Times Cited: 17
Privileged small molecules against neglected tropical diseases: A perspective from structure activity relationships
Jafar Abbasi Shiran, Babak Kaboudin, Nasrin Panahi, et al.
European Journal of Medicinal Chemistry (2024) Vol. 271, pp. 116396-116396
Closed Access | Times Cited: 2
Design, synthesis, and biological evaluation of quinoline-piperazine/pyrrolidine derivatives as possible antileishmanial agents
Sarita Katiyar, Ramalingam Karthik Raja, Abhishek Kumar, et al.
European Journal of Medicinal Chemistry (2023) Vol. 261, pp. 115863-115863
Closed Access | Times Cited: 6
An Atom-Economic Method for 1,2,3-Triazole Derivatives via Oxidative [3 + 2] Cycloaddition Harnessing the Power of Electrochemical Oxidation and Click Chemistry
Manas Bandyopadhyay, Sayan Bhadra, Swastik Pathak, et al.
The Journal of Organic Chemistry (2023) Vol. 88, Iss. 22, pp. 15772-15782
Closed Access | Times Cited: 5
Synthesis of New Imidazo[1,2‐a]pyridine Triazole Hybrid Molecules as Potential Apoptotic Antitumor Agents
Fatma Albayrak, Şebnem Eşsiz, Burak Servili, et al.
ChemistrySelect (2024) Vol. 9, Iss. 8
Closed Access | Times Cited: 1
Sojourn of Nitrogenous Heterocycles as Promising Antileishmanial Agents: Medicinal Perspectives and Structure–Activity Relationship Studies
Bhupender Nehra, Manoj Kumar, Sumitra Singh, et al.
Chemistry Africa (2024) Vol. 7, Iss. 7, pp. 3485-3529
Closed Access | Times Cited: 1
Synthesis of some novel 8-(4-Alkylpiperazinyl) caffeine derivatives as potent anti-Leishmania agents
Mohammad Navid Soltani Rad, Somayeh Behrouz, Kamran Zokaei, et al.
Bioorganic Chemistry (2022) Vol. 128, pp. 106062-106062
Closed Access | Times Cited: 8
Exploring Chemistry with Pyridine Derivatives

IntechOpen eBooks (2022)
Open Access | Times Cited: 7
Novel phenanthridine amide analogs as potential anti-leishmanial agents: In vitro and in silico insights
Adinarayana Nandikolla, Singireddi Srinivasarao, Banoth Karan Kumar, et al.
Bioorganic Chemistry (2021) Vol. 117, pp. 105414-105414
Closed Access | Times Cited: 9
Synthesis, biological assessment, and computational investigations of nifedipine and monastrol analogues as anti-leishmanial major and anti-microbial agents
Mahdieh Khalilzadeh, Sedigheh Saberi, Ghazal Noori, et al.
Molecular Diversity (2022) Vol. 27, Iss. 6, pp. 2555-2575
Closed Access | Times Cited: 6
A Step-By-Step Synthesis of S-Methylene Linker Containing Triazole-Benzoxazole Hybrids by Click Chemistry Approach: Anticancer Activity in Human Cells
Amita J. Jivani, Kaushik S. Lunagariya, Khushal M. Kapadiya, et al.
Analytical Chemistry Letters (2022) Vol. 12, Iss. 1, pp. 44-57
Open Access | Times Cited: 5
Design, Synthesis and Evaluation of Novel Phenanthridine Triazole Analogs as Potential Antileishmanial Agents
Adinarayana Nandikolla, Singireddi Srinivasarao, Banoth Karan Kumar, et al.
Future Medicinal Chemistry (2022) Vol. 14, Iss. 12, pp. 867-880
Closed Access | Times Cited: 4
An overview of synthetic approaches and the potential bioactivity of different 1,2,3-triazole hybrids
Wafaa A. Zaghary, Manal M. Anwar, Radwan El‐Haggar, et al.
Egyptian Pharmaceutical Journal (2024) Vol. 23, Iss. 2, pp. 157-183
Open Access
Synthesis of Imidazo[1,2‐b]pyridazine Scaffold Based Amide Derivatives as Potential Inhibitors for Bacterial Activity
Neelam Yesubabu, Dodda Bhargavi, Jyothi Prashanth, et al.
ChemistrySelect (2024) Vol. 9, Iss. 19
Closed Access
Synthesis of Nitrostyrylthiazolidine-2,4-dione Derivatives Displaying Antileishmanial Potential
Omar Khoumeri, Sébastien Hutter, Nicolas Primas, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 7, pp. 878-878
Open Access
The Synthesis of Triazolium Salts as Antifungal Agents: A Biological and In Silico Evaluation
Serghei Pogrebnoi, O. M. Радул, Eugenia Stingaci, et al.
Antibiotics (2022) Vol. 11, Iss. 5, pp. 588-588
Open Access | Times Cited: 3
A brief review on Triazole and its Pharmacological Application
Kuldeep T. Padhyar
International Journal of Current Science Research and Review (2022) Vol. 05, Iss. 01
Open Access | Times Cited: 2
Fused Pyridine Derivatives: Synthesis and Biological Activities
Hüseyin İstanbullu, Gülşah Bayraktar, Merve Saylam
IntechOpen eBooks (2022)
Open Access | Times Cited: 2
In vivo evaluation of anti-Leishmania activity of alkyltriazoles and alkylphosphocholines by oral route
Vanessa Silva Gontijo, Fábio Antônio Colombo, Patrícia Ferreira Espuri, et al.
Experimental Parasitology (2021) Vol. 226-227, pp. 108123-108123
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top